Press release
2025-2034 Chronic Pain Treatment Market Outlook: Key Drivers, Emerging Challenges, and Strategic Insights
Chronic Pain Treatment
What Will the Chronic Pain Treatment Industry Market Size Be by 2025?
The market size for treating chronic pain has seen robust growth over the recent years. The expansion is expected to go from $99.64 billion in 2024 to $109.05 billion in 2025, with a compound annual growth rate (CAGR) of 9.4%. Factors contributing to this growth in the past include an increase in the elderly population, escalating incidence of chronic illnesses, heightened awareness of pain management methods, an uptick in the usage of prescription opioids, and broader coverage of health insurance.
What's the Long-Term Growth Forecast for the Chronic Pain Treatment Market Size Through 2029?
In the coming years, the market size of chronic pain treatment is projected to experience substantial growth, swelling to $155 billion by 2029 with a 9.2% compound annual growth rate (CAGR). This projected surge during the forecast period is due to factors such as the trend towards non-opioid alternatives, increased governmental support for pain studies, a burgeoning demand for personalized medicine, a rising endorsement of digital tools for managing pain, and a growth in the application of AI for diagnostic and treatment planning purposes for pain. The dominant trends anticipated during the forecast period encompass advancements in neuromodulation therapies, the incorporation of telemedicine in pain management, the invention of therapies based on cannabi*noids, emphasis on multidisciplinary treatment strategies, and an ascent in wearable devices designed for monitoring pain.
View the full report here:
https://www.thebusinessresearchcompany.com/report/chronic-pain-treatment-global-market-report
What Are the Key Growth Drivers Fueling the Chronic Pain Treatment Market Expansion?
The chronic pain treatment market is expected to expand as arthritis pain becomes more common. Arthritis pain, which involves joint discomfort, aching, or soreness due to inflammation or degeneration, is largely caused by an aging population. This is because the natural wear and tear of joints increase with age, resulting in a higher occurrence of arthritis-related diseases. Chronic pain treatment aims to alleviate arthritis pain by focusing on inflammation and nerve sensitivity, improving joint function, and enhancing overall life quality for those constantly living with arthritis symptoms. For example, in March 2023, the UK's Office for Health Improvement and Disparities stated that in 2022, 17.6% people aged 16 and above are dealing with a long-term musculoskeletal condition, such as arthritis or ongoing back/joint issues, surpassing the 17.0% in 2021. Thus, the growing prevalence of arthritis pain is fuelling the growth of the chronic pain treatment market.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24504&type=smp
What Are the Key Trends Driving Chronic Pain Treatment Market Growth?
Dominant businesses in the chronic pain treatment market are shifting their strategic focus towards developing creative products such as rechargeable spinal cord stimulators. Such innovations are designed to boost patient comfort, and improve the results of enduring pain management. This rechargeable spinal cord stimulator is a medical appliance installed near the spinal area that transmits electronic pulses to suppress pain signals. It also allows for external recharging, eliminating the need for surgery. By disrupting the pain pathways in the spinal cord, it diminishes the sensation of pain in patients suffering from conditions like failed back surgery syndrome or neuropathic pain. For example, in December 2022, US medical device firm Abbott Laboratories introduced the Eterna spinal cord stimulation system. The Eterna device, smaller in size than an Apple AirPods case, provides a compact, discreet, and patient-friendly approach to handling chronic pain. It furnishes significant pain alleviation, demonstrated the potential to decrease dependence on opioids, and is engineered for prolonged, minimally invasive usage. Consequently, it boosts the patient's overall functionality and enhances their quality of life.
How Is the Chronic Pain Treatment Market Segmented?
The chronic pain treatment market covered in this report is segmented -
1) By Product Type: Drugs, Devices
2) By Indication: Neuropathic Pain, Arthritis Pain, Chronic Back Pain, Cancer Pain, Migraine, Fibromyalgia, Other Indications
3) By Distribution channels: Direct, Indirect
4) By End-User: Hospitals, Clinics, Nursing Homes, Research Centers And Universities, Other End-Users
Subsegments:
1) By Drugs: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Opioids, Antidepressants, Anticonvulsants, Muscle Relaxants, Topical Analgesics, Other Pain Relief Medications
2) By Devices: Neuromodulation Devices, Transcutaneous Electrical Nerve Stimulation (TENS) Devices, Spinal Cord Stimulators, Peripheral Nerve Stimulators, Radiofrequency Ablation Devices, Implantable Drug Delivery Devices
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=24504&type=smp
Which Companies Are Leading the Charge in Chronic Pain Treatment Market Innovation?
Major companies operating in the chronic pain treatment market are Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, Abbott Laboratories, Novartis AG, GlaxoSmithKline plc, Medtronic plc, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim International GmbH, Boston Scientific Corporation, Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Amneal Pharmaceuticals LLC, Mallinckrodt plc, Nevro Corp.
Which Regions Are Leading the Global Chronic Pain Treatment Market in Revenue?
North America was the largest region in the chronic pain treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chronic pain treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase the full report to*day:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=24504
This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Learn More About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release 2025-2034 Chronic Pain Treatment Market Outlook: Key Drivers, Emerging Challenges, and Strategic Insights here
News-ID: 4092397 • Views: …
More Releases from The Business Research Company
Unlocking Opportunities in the Tyrosine Kinase Inhibitors Market: 2025-2034 Fore …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Tyrosine Kinase Inhibitors Industry Market Size Be by 2025?
The market for tyrosine kinase inhibitors has seen robust growth in recent times. The market is predicted to expand from $58.03 billion in 2024 to $62.66 billion in 2025, marking a compound annual growth rate (CAGR) of…
Sustained Release Excipients Market Advances With Product Innovation Industry Tr …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Sustained Release Excipients Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
In recent times, the market size of sustained release excipients has seen significant growth. It's projected to increase from $1.4 billion in 2024 to $1.51 billion in 2025, exhibiting a Compound Annual Growth Rate…
Surge In Cancer Cases Fuels Expansion Of The RNA-Targeting Small Molecule Therap …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the RNA Targeting Small Molecules Therapeutics Market Size By 2025?
In recent years, the market size of RNA targeting small molecules therapeutics has witnessed substantial growth. The market, which is estimated to be worth $6.1 billion in 2024, is projected to increase to $7.83 billion in…
Surge In Autoimmune Diseases Fuels Remicade Biosimilar Market Growth Emerges as …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Remicade Biosimilar Market Through 2025?
In recent times, we've seen significant expansion in the remicade biosimilar market. Projected growth from 2024's $3.95 billion to $4.89 billion in 2025 indicates a compound annual growth rate (CAGR) of 23.8%. This rise during the historic…
More Releases for Pain
Enhanced Pain Relief Solutions at Advanced Pain Care
Image: https://www.globalnewslines.com/uploads/2025/03/3f3b6259bfdec02e5dcb7b9d0c838855.jpg
Advanced Pain Care is helping people who suffer from chronic pain with sophisticated, evidence-based treatments. The clinic is particularly focused on non-surgical care that improves the quality of life. With a team of highly qualified pain experts, they work with patients who have back pain, joint pain, and nerve pain.
Personalized Treatment for Every Pain Disorder
Advanced Pain Care offers treatments depending on the cause of pain. Anyone experiencing arthritis, migraine,…
Pain Finisher | Advanced Pain Relief Device
Pain Finisher is an instant pain relief device that is effective on all pains including back pain and knee pain. It is based on the TENS theory of pain management which is easy to use and safe.
By using Pain Finisher, a modern drug-free and non-invasive pain-relieving treatment method, one can get rid of the common pain creams, gels, and risky treatment methods.
So, have a pain-free life with easy-to-use pain relief…
Neuropathic Pain Market: Innovative Therapies Reshaping Chronic Pain Management
In recent years, the global Neuropathic Pain Market has witnessed a dynamic shift, influenced by changing consumer preferences, technological advancements, and a growing emphasis on sustainability. The Research report on Neuropathic Pain Market presents a complete judgment of the market through strategic insights on future trends, growth factors, supplier landscape, demand landscape, Y-o-Y growth rate, CAGR, pricing analysis. It also provides and a lot of business matrices including…
Visceral Pain Market Analysis 2024: Addressing Pain Management Challenges
The Business Research Company has released its latest global market reports, covering insights for 2024 and offering projections up to 2033.
The Business Research Company presents an extensive market research report on the Visceral Pain Global Market Report 2024, furnishing businesses with a competitive edge through a detailed examination of the market structure, encompassing estimates for various segments and sub-segments.
Furthermore, the report highlights on emerging trends, significant drivers, challenges, and opportunities,…
Global Post-Operative Pain Management Market: Pain Relief Goes Worldwide
Introduction:
The Global Post-Operative Pain Management Market is growing at a rapid pace. This market involves the management of pain after surgical procedures. The market has witnessed significant growth in recent years, owing to the increasing number of surgeries and the rising prevalence of chronic diseases. Pain management is an essential aspect of healthcare, as uncontrolled pain can lead to prolonged hospital stays, delayed recovery, and poor patient outcomes.
In this article,…
Post-Operative Pain Management Market By Type, By Application(Cancer Pain, Arthr …
Global Post-Operative Pain Management Market- Description
Post-operative pain management is predominantly referred to as the use of a wide array of therapies or drugs to reduce muscle and tissue spasm in patients who have recently undergone a surgical procedure. It is evident that all type of surgeries, be it major or minor cause postoperative pain in patients which in turn increases their hospital stays while burdening them with psychological and physical…
